This risk is further increased by a reduction in SHBG in the liver of individuals with obesity and an increase in the concentration of non-SHBG-bound estradiol (E2, the most abundant and active estrogen) (44, 45). This evidence concerns the gene SHBG and obesity due to melanocortin 4 receptor deficiency.